The mechanistic and functional profile of the therapeutic anti-IgE antibody ligelizumab differs from omalizumab

Authors
Publication date
Publisher
'Springer Science and Business Media LLC'
Doi

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Crossref

      redirect
      Last time updated on 17/06/2021